Aprepitant 40mg

DRUG2 trials

Sponsors

Sharon Walsh, Centre hospitalier de l'Université de Montréal (CHUM)

Conditions

Narcotic AbuseNausea and Vomiting, PostoperativePrevention

Phase 3

Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical Patients

CompletedNCT07248280

Centre hospitalier de l'Université de Montréal (CHUM)Nausea and Vomiting, Postoperative, Prevention

Start: 2026-02-27End: 2026-08-14Updated: 2026-08-27

Unknown Phase

Aprepitant Effects on Oxycodone Response

CompletedNCT00999544

Sharon WalshNarcotic Abuse

Start: 2009-10-31End: 2011-04-30Updated: 2017-09-01